Eli Lilly and (LLY) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased compared to both the previous quarter and the same quarter one year earlier. The reported growth reflects continued business momentum.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased compared to both the previous quarter and the same quarter one year earlier. The reported growth reflects continued business momentum.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.3B
Revenue reported for this quarter.
Quarter-over-quarter
+19.4%
Change from the immediately preceding quarter.
Year-over-year
+28.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$29.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $6.9B | +2.5% |
| Dec 31, 2022 | $7.3B | -8.7% |
| Mar 31, 2023 | $7B | -10.9% |
| Jun 30, 2023 | $8.3B | +28.1% |
Revenue performance
Revenue rose sequentially from the immediate prior quarter and was also higher on a year-over-year basis.
Quarterly comparison
The sequential increase represents an acceleration from the previous quarter, while the year-over-year gain further outpaces the prior year's same period.
What to watch
Future quarters will show whether revenue growth can be sustained.